Key Highlights

  • Turning Point Brands' $0.08 quarterly Dividend has a Record Date of September 18, 2026, payable October 9, yielding approximately 0.46%.
  • Second-quarter consolidated net sales were $142.96 million, up 22.6% year over year, with Modern Oral sales up approximately 128% to represent about 48% of total revenue.
  • Gross profit rose 40.6% to $93.7 million, including $17.8 million of Tariff refunds; adjusted Gross Profit was $81.5 million.
  • SG&A rose 91.1% to $76.9 million as the company increased marketing, sales and freight spending behind Modern Oral expansion.

Turning Point Brands' (NYSE:TPB) $0.08 quarterly dividend yields approximately 0.46% and represents a small proportion of the company's cash position, maintained even as the company invests heavily in expanding its Modern Oral segment, which grew approximately 128% year over year to represent 48% of total revenue. Cash at quarter-end was $268.3 million and total Liquidity was approximately $339 million, giving management substantial capacity to fund growth Investment alongside the regular dividend.

Dividend Program and Shareholder Returns

Turning Point Brands declared a regular quarterly dividend of $0.08 per common share, payable October 9, 2026 to shareholders of record September 18, 2026. The annualized rate is $0.32 per share if maintained. The dividend is relatively small compared with the company's current investment in Modern Oral expansion.

About the Company

Turning Point Brands is a U.S. consumer-products company focused on Other Tobacco Products and alternative nicotine categories, including Stoker's, Modern Oral products and vapor-related products sold through convenience stores and other retail channels.

Financial Performance Behind the Payout

Turning Point Brands reported Q2 2026 consolidated net sales of $142.96 million, up 22.6% year over year. Gross profit was $93.7 million, up 40.6%, including $17.8 million of tariff refunds. Adjusted gross profit was $81.5 million, producing a 57% adjusted gross margin. Diluted EPS was $0.18 versus $0.79 a year earlier, while adjusted diluted EPS was $0.23. SG&A rose 91.1% to $76.9 million as the company increased marketing, sales and freight spending.

Modern Oral Investment Trades Near-Term Margin for Category Growth

Modern Oral sales increased approximately 128% year over year in Q2 and represented about 48% of total revenue. Management raised its full-year Modern Oral guidance while continuing to invest heavily in distribution, Marketing and Brand development, investments that contributed to the 91.1% SG&A increase and kept adjusted EBITDA under pressure despite strong sales growth. The company also continues pursuing regulatory progress and international expansion for its Modern Oral portfolio.

Outlook

Turning Point Brands' dividend represents a small proportion of the company's cash position, with the $0.08 quarterly rate maintained through continued heavy investment in Modern Oral expansion. Metrics relevant to the payout's context going forward include the pace of Modern Oral distribution and market-share gains, margin trends once current investment levels normalize, and progress on regulatory approvals for international expansion.